NasdaqGM - Nasdaq Real Time Price USD

Larimar Therapeutics, Inc. (LRMR)

Compare
6.17 +0.06 (+0.98%)
At close: December 13 at 4:00:01 PM EST
6.17 0.00 (0.00%)
After hours: 7:59:22 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
73,759.00
41,758.00
36,526.00
50,465.00
42,804.00
Operating Income
-73,759.00
-41,758.00
-36,526.00
-50,465.00
-42,804.00
Other Income Expense
8,986.00
4,809.00
1,171.00
-171.00
322.00
Pretax Income
-64,773.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Net Income Common Stockholders
-64,773.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Diluted NI Available to Com Stockholders
-64,773.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Basic EPS
-1.12
-0.84
-1.37
-2.95
-3.57
Diluted EPS
-1.12
-0.84
-1.37
-2.95
-3.57
Basic Average Shares
51,291.31
43,901.24
25,761.39
17,164.28
11,883.11
Diluted Average Shares
51,291.31
43,901.24
25,761.39
17,164.28
11,883.11
Total Operating Income as Reported
-73,759.00
-41,758.00
-36,526.00
-50,465.00
-42,804.00
Total Expenses
73,759.00
41,758.00
36,526.00
50,465.00
42,804.00
Net Income from Continuing & Discontinued Operation
-64,773.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Normalized Income
-64,773.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
EBIT
-73,759.00
-41,758.00
-36,526.00
-50,465.00
-42,804.00
EBITDA
-73,437.00
-41,447.00
-36,208.00
-50,139.00
-42,649.00
Reconciled Depreciation
322.00
311.00
318.00
326.00
155.00
Net Income from Continuing Operation Net Minority Interest
-64,773.00
-36,949.00
-35,355.00
-50,636.00
-42,482.00
Normalized EBITDA
-73,437.00
-41,447.00
-36,208.00
-50,139.00
-42,649.00
12/31/2020 - 6/19/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CRVS Corvus Pharmaceuticals, Inc.
7.38
-8.66%
 
INZY Inozyme Pharma, Inc.
3.0300
+1.68%
 
SLRN Acelyrin, Inc.
3.2300
-8.76%
 
STOK Stoke Therapeutics, Inc.
12.06
-2.11%
 
ATYR aTyr Pharma, Inc.
3.0600
+1.32%
 
SPRB Spruce Biosciences, Inc.
0.3832
-1.01%
 
DAWN Day One Biopharmaceuticals, Inc.
12.75
-0.47%
 
ANAB AnaptysBio, Inc.
15.59
+3.79%
 
EWTX Edgewise Therapeutics, Inc.
27.62
-1.88%
 
BCYC Bicycle Therapeutics plc
13.81
-31.33%